Jamie A. Donadio
2019
Compensation breakdown
| Non-Equity Incentive Plan | $186,950 |
|---|---|
| Option Awards | $2,637,984 |
| Salary | $373,900 |
| Other | $2,500 |
| Total | $3,201,334 |
Donadio received $2.6M in option awards, accounting for 82% of the total pay in 2019.
Donadio also received $187K in non-equity incentive plan, $373.9K in salary and $2.5K in other compensation.
Rankings
In 2019, Jamie A. Donadio's compensation ranked 3,810th out of 13,971 executives tracked by ExecPay. In other words, Donadio earned more than 72.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,810 out of 13,971 | 73rd |
Division Manufacturing | 1,377 out of 5,695 | 76th |
Major group Chemicals And Allied Products | 483 out of 2,194 | 78th |
Industry group Drugs | 407 out of 1,880 | 78th |
Industry Pharmaceutical Preparations | 308 out of 1,392 | 78th |
Pay ratio
| Jamie A. Donadio's Pay | $3,201,334 |
|---|---|
| Median Employee's Pay | $588,168 |
| Pay Ratio | 5to 1 |
In 2019, the annual total compensation of Jamie A. Donadio was $3,201,334.
The annual total compensation of the median employee at Mirati Therapeutics was $588,168.
The ratio of Jamie A. Donadio's pay to the pay of median employee was therefore 5 to one.
Donadio's colleagues
We found four more compensation records of executives who worked with Jamie A. Donadio at Mirati Therapeutics in 2019.
2019
Charles Baum
Mirati Therapeutics
Chief Executive Officer
2019
James Christensen
Mirati Therapeutics
Chief Scientific Officer
2019
Isan Chen
Mirati Therapeutics
Executive Vice President and Chief Medical and Development Officer
2019
Chris LeMasters
Mirati Therapeutics